BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21457190)

  • 1. Screening for CRLF2 overexpression in adult acute lymphoblastic leukemia.
    Haslam K; Kelly J; Morris T; Connaghan G; Gilligan O; Browne P; Langabeer SE
    Int J Lab Hematol; 2011 Dec; 33(6):e17-9. PubMed ID: 21457190
    [No Abstract]   [Full Text] [Related]  

  • 2. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
    Moorman AV; Schwab C; Ensor HM; Russell LJ; Morrison H; Jones L; Masic D; Patel B; Rowe JM; Tallman M; Goldstone AH; Fielding AK; Harrison CJ
    J Clin Oncol; 2012 Sep; 30(25):3100-8. PubMed ID: 22851563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.
    Hertzberg L; Vendramini E; Ganmore I; Cazzaniga G; Schmitz M; Chalker J; Shiloh R; Iacobucci I; Shochat C; Zeligson S; Cario G; Stanulla M; Strehl S; Russell LJ; Harrison CJ; Bornhauser B; Yoda A; Rechavi G; Bercovich D; Borkhardt A; Kempski H; te Kronnie G; Bourquin JP; Domany E; Izraeli S
    Blood; 2010 Feb; 115(5):1006-17. PubMed ID: 19965641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
    Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
    Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
    Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
    Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.
    Younan S; Elhoseiny S; Hammam A; Gawdat R; El-Wakil M; Fawzy M
    Leuk Res; 2012 Feb; 36(2):169-73. PubMed ID: 21978468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities.
    Chiaretti S; Brugnoletti F; Messina M; Paoloni F; Fedullo AL; Piciocchi A; Elia L; Vitale A; Mauro E; Ferrara F; De Fabritiis P; Luppi M; Ronco F; De Propris MS; Raponi S; Kronnie GT; Vignetti M; Guarini A; Foà R
    Leuk Res; 2016 Feb; 41():36-42. PubMed ID: 26754556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Karyotype refinement by multicolor fluorescence in situ hybridization analysis in 18 patients with acute lymphoblastic leukemia.
    Calabrese G; Taraborelli T; Fantasia D; Guanciali Franchi P; Spadano A; Palka G
    Haematologica; 2002 Aug; 87(8):888-9. PubMed ID: 12161369
    [No Abstract]   [Full Text] [Related]  

  • 9. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience.
    Konoplev S; Lu X; Konopleva M; Jain N; Ouyang J; Goswami M; Roberts KG; Valentine M; Mullighan CG; Bueso-Ramos C; Zweidler-McKay PA; Jorgensen JL; Wang SA
    Am J Clin Pathol; 2017 Apr; 147(4):357-363. PubMed ID: 28340183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKZF1 alterations and expression of CRLF2 predict prognosis in adult Chinese patients with B-cell precursor acute lymphoblastic leukemia.
    Fang Q; Zhao X; Li Q; Li Y; Liu K; Tang K; Wang Y; Liu B; Wang M; Xing H; Rao Q; Tian Z; Wang J; Mi Y
    Leuk Lymphoma; 2017 Jan; 58(1):127-137. PubMed ID: 27157479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients.
    Jain N; Lu X; Daver N; Thakral B; Wang SA; Konoplev S; Patel K; Kanagal-Shamanna R; Valentine M; Tang G; Pemmaraju N; Jorgensen J; Kebriaei P; Nunez CA; Wierda W; Jabbour E; Roberts KG; Mullighan CG; Kantarjian H; Konopleva M
    Haematologica; 2017 Dec; 102(12):e514-e517. PubMed ID: 28860345
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.
    Russell LJ; Jones L; Enshaei A; Tonin S; Ryan SL; Eswaran J; Nakjang S; Papaemmanuil E; Tubio JM; Fielding AK; Vora A; Campbell PJ; Moorman AV; Harrison CJ
    Genes Chromosomes Cancer; 2017 May; 56(5):363-372. PubMed ID: 28033648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients.
    Chevallier P; Robillard N; Wuilleme-Toumi S; Méchinaud F; Harousseau JL; Avet-Loiseau H
    Haematologica; 2004 Nov; 89(11):1399-401. PubMed ID: 15531467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.
    Lasa A; Serrano E; Carricondo M; Carnicer MJ; Brunet S; Badell I; Sierra J; Aventín A; Nomdedéu JF
    Ann Hematol; 2008 Mar; 87(3):205-11. PubMed ID: 17909799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of BCR-ABL molecular testing in acute leukemia.
    Nashed AL; Rao KW; Gulley ML
    J Mol Diagn; 2003 May; 5(2):63-72. PubMed ID: 12707370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia.
    O'Reilly J; Russell LJ; Cooney J; Ensor HM; Purtill D; Wright M; Moorman AV
    Pathology; 2013 Oct; 45(6):609-12. PubMed ID: 24018820
    [No Abstract]   [Full Text] [Related]  

  • 18. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
    Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
    Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Philadelphia chromosome-positive acute lymphoblastic leukemia: a cytogenetic study of 33 patients diagnosed between 1981 and 2008.
    De Braekeleer E; Douet-Guilbert N; Morel F; Le Bris MJ; Basinko A; Berthou C; Morice P; Férec C; De Braekeleer M
    Anticancer Res; 2010 Feb; 30(2):569-73. PubMed ID: 20332472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.